Legal Opinion
Procter & Gamble Co. v. Teva Pharmaceuticals USA, Inc.
Court of Appeals for the Federal Circuit
Decided May 13, 2009No. 2008-1404, 2008-1405, 2008-1406PublishedCited by 161 opinions
1Opinion of the Court
HUFF, District Judge.
Teva Pharmaceuticals USA, Inc. (“Teva”) appeals from a final judgment of the United States District Court for the District of Delaware in favor of The Procter & Gamble Company (“P & G”) in three cases upholding, the validity of P & G’s U.S. Patent 5,583,122 (the “'122 patent”). Proctor & Gamble Co. v. Teva Pharmaceuticals USA, Inc., 536 F.Supp.2d 476 (D.Del.2008). After a bench trial and a stipulation for judgment in the related cases, the district court rejected Teva’s invalidity defenses of obviousness and obviousness-type double patenting. We affirm.
I. BACKGROUND
The…
2Cases cited27 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Stratoflex, Inc. v. Aeroquip CorporationCourt of Appeals for the Federal Circuit · 1983
- Colorado v. New MexicoSupreme Court of the United States · 1984
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
22 more not listed; retrieve them via the Exa API.
3Cited by161 opinions
- I4i Ltd. Partnership v. Microsoft Corp.Court of Appeals for the Federal Circuit · 2010
- Eurand, Inc. v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2012
- Activevideo Networks, Inc. v. Verizon Communications, Inc.Court of Appeals for the Federal Circuit · 2012
- Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd.Court of Appeals for the Federal Circuit · 2016
- Kinetic Concepts, Inc. v. Smith & Nephew, Inc.Court of Appeals for the Federal Circuit · 2012
156 more not listed; retrieve them via the Exa API.